Abdullah M.M. Faqehi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Benign prostatic hyperplasia and prostate cancer can be treated with the 5α-reductase inhibitors, finasteride and dutasteride, when pharmacodynamic biomarkers are useful in assessing response. A novel method was developed to measure the substrates and products of 5α-reductases (testosterone, 5α-dihydrotestosterone (DHT), androstenedione) and finasteride and(More)
  • 1